All Stories

  1. New Kidneys, Old Risks: Cardiovascular Challenges After Transplantation

    Article • Nephrology Dialysis Transplantation, November 2025, Oxford University Press (OUP)

    Prof. Dr. Johannes Stegbauer

  2. Sodium as an Important Regulator of Immunometabolism

    Article • Hypertension, March 2024, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  3. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

    Article • Journal of the American Society of Nephrology, December 2023, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  4. Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health

    Article • British Journal of Pharmacology, September 2023, Wiley

    Prof. Dr. Johannes Stegbauer

  5. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

    Article • JAMA Cardiology, May 2023, American Medical Association (AMA)

    Prof. Dr. Johannes Stegbauer

  6. Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs

    Article • Cell Metabolism, February 2023, Elsevier

    Prof. Dr. Johannes Stegbauer

  7. The Effect of Renal Denervation on T Cells in Patients with Resistant Hypertension

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Prof. Dr. Johannes Stegbauer

  8. Empagliflozin in Patients with Chronic Kidney Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2023, New England Journal of Medicine (NEJM/MMS)

    Prof. Dr. Johannes Stegbauer

  9. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    Article • The Lancet, December 2022, Elsevier

    Professor Yuriy M. Sirenko, Prof. Dr. Johannes Stegbauer

  10. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation

    Article • JAMA Cardiology, December 2022, American Medical Association (AMA)

    Prof. Dr. Johannes Stegbauer

  11. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients

    Article • The Journal of Infectious Diseases, November 2022, Oxford University Press (OUP)

    Prof. Dr. Johannes Stegbauer

  12. 19F-MRT basierte Visualisierung von entzündlichen Prozessen im Gefäßsystem

    Article • Gefässchirurgie, October 2022, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  13. Cardiomyocyte p38 MAPKα suppresses a heart–adipose tissue–neutrophil crosstalk in heart failure development

    Article • Basic Research in Cardiology, October 2022, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  14. Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients

    Article • Frontiers in Immunology, October 2022, Frontiers

    Prof. Dr. Johannes Stegbauer

  15. Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction

    Article • Clinical Transplantation, September 2022, Wiley

    Prof. Dr. Johannes Stegbauer

  16. Immunadsorption zur Herstellung von COVID-19 Antikörperkonzentraten

    Article • Transfusionsmedizin, August 2022, Thieme Publishing Group

    Prof. Dr. Johannes Stegbauer

  17. Development and Validation of Multivariable Prediction Models of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Article • June 2022, Cold Spring Harbor Laboratory Press

    Prof. Dr. Johannes Stegbauer

  18. Inhibition of p38 MAPK decreases hyperglycemia-induced nephrin endocytosis and attenuates albuminuria

    Article • Journal of Molecular Medicine, April 2022, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  19. Rapid shear stress-dependent ENaC membrane insertion is mediated by the endothelial glycocalyx and the mineralocorticoid receptor

    Article • Cellular and Molecular Life Sciences, April 2022, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  20. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients

    Article • Arabian archaeology and epigraphy, February 2022, Elsevier

    Prof. Dr. Johannes Stegbauer

  21. Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism

    Article • Frontiers in Cardiovascular Medicine, January 2022, Frontiers

    Prof. Dr. Johannes Stegbauer

  22. Beyond Vessel Diameters: Non-invasive Monitoring of Flow Patterns and Immune Cell Recruitment in Murine Abdominal Aortic Disorders by Multiparametric MRI

    Article • Frontiers in Cardiovascular Medicine, October 2021, Frontiers

    Prof. Dr. Johannes Stegbauer

  23. COVID-19 antibody donation using immunoadsorption: Report of two cases

    Article • Transfusion and Apheresis Science, October 2021, Elsevier

    Prof. Dr. Johannes Stegbauer

  24. Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure

    Article • Circulation, September 2021, Wolters Kluwer Health

    Bernadette Fernandez, Prof. Dr. Johannes Stegbauer

  25. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients

    Article • Kidney360, September 2021, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  26. Salt Transiently Inhibits Mitochondrial Energetics in Mononuclear Phagocytes

    Article • Circulation, July 2021, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  27. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

    Article • The Lancet, June 2021, Elsevier

    Prof. Dr. Johannes Stegbauer

  28. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury

    Article • Nature Reviews Nephrology, May 2021, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  29. Direct Actions of AT 1 (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy

    Article • Hypertension, February 2021, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  30. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation

    Article • Hypertension, February 2021, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  31. Update: Selective adrenal venous sampling (AVS) – Indication, technique, and significance

    Article • RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, December 2020, Thieme Publishing Group

    Prof. Dr. Johannes Stegbauer

  32. Proteomic Analysis Reveals Upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the Putative SARS-CoV-2 Receptor in Pressure–but Not Volume-Overloaded Human Hearts

    Article • Hypertension, December 2020, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  33. Role of α2-Adrenoceptors in Hypertension: Focus on Renal Sympathetic Neurotransmitter Release, Inflammation, and Sodium Homeostasis

    Article • Frontiers in Physiology, November 2020, Frontiers

    Prof. Dr. Johannes Stegbauer

  34. Critical Role of Neprilysin in Kidney Angiotensin Metabolism

    Article • Circulation Research, August 2020, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  35. Alpha2A-adrenoceptors protect against hypertensive kidney disease.

    Article • Journal of the American Society of Nephrology, February 2020, American Society of Nephrology

    Prof. Dr. Johannes Stegbauer

  36. Platelet reactivity in patients with chronic kidney disease and hemodialysis

    Article • Journal of Thrombosis and Thrombolysis, November 2019, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  37. Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice

    Article • Journal of Vascular Surgery, November 2019, Elsevier

    Prof. Dr. Johannes Stegbauer

  38. Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70

    Article • Journal of Visualized Experiments, August 2019, MyJove Corporation

    Prof. Dr. Johannes Stegbauer

  39. Renale Rindennekrose nach Gabe von Tranexamsäure bei geburtsassoziierter Blutung

    Article • DMW - Deutsche Medizinische Wochenschrift, May 2019, Thieme Publishing Group

    Prof. Dr. Johannes Stegbauer

  40. Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage

    Article • Circulation, March 2019, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  41. Isolation of Glomeruli and <em>In Vivo</em> Labeling of Glomerular Cell Surface Proteins

    Article • Journal of Visualized Experiments, January 2019, MyJove Corporation

    Prof. Dr. Johannes Stegbauer

  42. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

    Article • The Lancet, June 2018, Elsevier

    Prof. Dr. Johannes Stegbauer

  43. Impact of the NO-Sensitive Guanylyl Cyclase 1 and 2 on Renal Blood Flow and Systemic Blood Pressure in Mice

    Article • International Journal of Molecular Sciences, March 2018, MDPI AG

    Prof. Dr. Johannes Stegbauer

  44. Erythrocyte Salt Sedimentation Assay Does Not Predict Response to Renal Denervation

    Article • Frontiers in Medicine, March 2018, Frontiers

    Prof. Dr. Johannes Stegbauer

  45. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice

    Article • Pflügers Archiv - European Journal of Physiology, January 2018, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  46. A novel in vivo method to quantify slit diaphragm protein abundance in murine proteinuric kidney disease

    Article • PLOS One, June 2017, PLOS

    Prof. Dr. Johannes Stegbauer

  47. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury

    Article • Antioxidants & Redox Signaling, April 2017, Mary Ann Liebert Inc

    Prof. Dr. Johannes Stegbauer

  48. Resistance to hypertension mediated by intercalated cells of the collecting duct

    Article • JCI Insight, April 2017, American Society for Clinical Investigation

    Prof. Dr. Johannes Stegbauer

  49. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction

    Article • AJP Renal Physiology, March 2017, American Physiological Society

    Prof. Dr. Johannes Stegbauer

  50. Macrophages in neuroinflammation: role of the renin-angiotensin-system

    Article • Pflügers Archiv - European Journal of Physiology, February 2017, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  51. Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis

    Article • Scientific Reports, December 2016, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  52. Role of the receptor Mas in macrophage-mediated inflammation in vivo

    Article • Proceedings of the National Academy of Sciences, November 2016, Proceedings of the National Academy of Sciences

    Prof. Dr. Johannes Stegbauer

  53. Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation

    Article • Neuropharmacology, November 2016, Elsevier

    Prof. Dr. Johannes Stegbauer

  54. Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney

    Article • Scientific Reports, September 2016, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  55. Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension

    Article • Journal of the Renin-Angiotensin-Aldosterone System, July 2016, SAGE Publications

    Prof. Dr. Johannes Stegbauer

  56. Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension

    Article • Hypertension, June 2016, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  57. Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension

    Article • Current Hypertension Reports, April 2016, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  58. Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion

    Article • Journal of the American Society of Nephrology, December 2015, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  59. Angiotensin II-Induced Hypertension Is Attenuated by Reduction of Sympathetic Output in NO-Sensitive Guanylyl Cyclase 1 Knockout Mice

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Prof. Dr. Johannes Stegbauer

  60. Skin tight: macrophage-specific COX-2 induction links salt handling in kidney and skin

    Article • Journal of Clinical Investigation, October 2015, American Society for Clinical Investigation

    Prof. Dr. Johannes Stegbauer

  61. Coronary artery stenosis: a new risk factor for chronic kidney injury?

    Article • Kidney International, April 2015, Elsevier

    Prof. Dr. Johannes Stegbauer

  62. Sustained hypertension despite endothelial-specific eNOS rescue in eNOS-deficient mice

    Article • Biochemical and Biophysical Research Communications, March 2015, Elsevier

    Prof. Dr. Johannes Stegbauer

  63. Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease

    Article • Molecular Neurodegeneration, November 2014, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  64. Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease

    Article • Journal of Neuroimmune Pharmacology, May 2014, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  65. Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor–mediated kidney fibrosis

    Article • Journal of Clinical Investigation, April 2014, American Society for Clinical Investigation

    Prof. Dr. Johannes Stegbauer

  66. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events

    Article • Arthritis Research & Therapy, February 2014, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  67. Angiotensin-(1–7) Modulates Renal Vascular Resistance Through Inhibition of p38 Mitogen-Activated Protein Kinase in Apolipoprotein E–Deficient Mice

    Article • Hypertension, February 2014, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  68. Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular Hypertension

    Article • PLOS One, November 2013, PLOS

    Prof. Dr. Johannes Stegbauer

  69. P2Y2 receptor deficiency aggravates chronic kidney disease progression

    Article • Frontiers in Physiology, January 2013, Frontiers

    Prof. Dr. Johannes Stegbauer

  70. Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study

    Article • Rheumatology, December 2011, Oxford University Press (OUP)

    Prof. Dr. Johannes Stegbauer

  71. AT1 Receptors in the Collecting Duct Directly Modulate the Concentration of Urine

    Article • Journal of the American Society of Nephrology, December 2011, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  72. Chronic treatment with angiotensin‐(1‐7) improves renal endothelial dysfunction in apolipoproteinE‐deficient mice

    Article • British Journal of Pharmacology, June 2011, Wiley

    Prof. Dr. Johannes Stegbauer

  73. Regulation of renal sympathetic neurotransmission by renal α2A‐adrenoceptors is impaired in chronic renal failure

    Article • British Journal of Pharmacology, April 2011, Wiley

    Prof. Dr. Johannes Stegbauer

  74. PKCα Mediates β-Arrestin2-dependent Nephrin Endocytosis in Hyperglycemia

    Article • Journal of Biological Chemistry, April 2011, Elsevier

    Prof. Dr. Johannes Stegbauer

  75. Angiotensin II Type 1A Receptors in Vascular Smooth Muscle Cells Do Not Influence Aortic Remodeling in Hypertension

    Article • Hypertension, March 2011, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  76. Treatment of obstructive sleep apnea reduces arterial stiffness

    Article • Sleep And Breathing, January 2011, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  77. New insights into angiotensin receptor actions: from blood pressure to aging

    Article • Current Opinion in Nephrology & Hypertension, January 2011, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  78. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension

    Article • Journal of Human Hypertension, November 2010, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  79. The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure

    Article • Nephrology Dialysis Transplantation, August 2010, Oxford University Press (OUP)

    Prof. Dr. Johannes Stegbauer

  80. Influence of genetic background on albuminuria and kidney injury in Ins2+/C96Y (Akita) mice

    Article • AJP Renal Physiology, March 2010, American Physiological Society

    Prof. Dr. Johannes Stegbauer

  81. A Role for Angiotensin II Type 1 Receptors on Bone Marrow-Derived Cells in the Pathogenesis of Angiotensin II–Dependent Hypertension

    Article • Hypertension, January 2010, Wolters Kluwer Health

    MD, PhD Pierre-Louis Tharaux, Prof. Dr. Johannes Stegbauer

  82. Small but powerful: Short peptide hormones and their role in autoimmune inflammation

    Article • Journal of Neuroimmunology, December 2009, Elsevier

    Prof. Dr. Johannes Stegbauer

  83. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system

    Article • Proceedings of the National Academy of Sciences, September 2009, Proceedings of the National Academy of Sciences

    Prof. Dr. Johannes Stegbauer

  84. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting – A case report and review of the literature

    Article • Clinical Nephrology, November 2008, Dustri-Verlgag Dr. Karl Feistle

    Prof. Dr. Johannes Stegbauer

  85. The glomerular proteome in a model of chronic kidney disease

    Article • PROTEOMICS - CLINICAL APPLICATIONS, July 2008, Wiley

    Prof. Dr. Johannes Stegbauer

  86. A Tale of Two Patients With Mendelian Hypertension

    Article • Hypertension, March 2008, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  87. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase

    Article • AJP Regulatory Integrative and Comparative Physiology, February 2008, American Physiological Society

    Prof. Dr. Johannes Stegbauer

  88. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release

    Article • AJP Regulatory Integrative and Comparative Physiology, February 2008, American Physiological Society

    Prof. Dr. Johannes Stegbauer

  89. Vergleich von Bildgebung und seitengetrennter Nebennierenvenen-Blutentnahme zur Differentialdiagnose bei primärem Hyperaldosteronismus

    Article • DMW - Deutsche Medizinische Wochenschrift, November 2007, Thieme Publishing Group

    Prof. Dr. Johannes Stegbauer

  90. Sites of inflammation in painful rheumatoid shoulder assessed by musculoskeletal ultrasound and power Doppler sonography

    Article • Rheumatology International, October 2007, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  91. Renaler Widerstandsindex bei obstruktiver Schlafapnoe

    Article • DMW - Deutsche Medizinische Wochenschrift, September 2007, Thieme Publishing Group

    Prof. Dr. Johannes Stegbauer

  92. α2A‐Adrenoceptors Regulate Sympathetic Transmitter Release in Mice Kidneys

    Article • British Journal of Pharmacology, January 2007, Wiley

    Prof. Dr. Johannes Stegbauer

  93. Novel approaches to analyse glomerular proteins from smallest scale murine and human samples using DIGE saturation labelling

    Article • PROTEOMICS, August 2006, Wiley

    Prof. Dr. Johannes Stegbauer

  94. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension

    Article • Journal of Hypertension, November 2005, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  95. Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice

    Article • Journal of Hypertension, September 2005, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  96. Dihydrotachysterol Therapy for Hypoparathyroidism: Consequences of Inadequate Monitoring. Five Cases and a Review

    Article • Experimental and Clinical Endocrinology & Diabetes, July 2005, Thieme Publishing Group

    Prof. Dr. Johannes Stegbauer

  97. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneoulsy hypertensive rats

    Article • Cardiovascular Research, May 2005, European Society of Cardiology

    Prof. Dr. Johannes Stegbauer

  98. Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X1,3‐ and P2Y6‐like receptors in mouse perfused kidney

    Article • British Journal of Pharmacology, May 2005, Wiley

    Prof. Dr. Johannes Stegbauer

  99. Angiotensin II Receptor Modulation of Renal Vascular Resistance and Neurotransmission in Young and Adult Spontaneously Hypertensive Rats

    Article • Kidney and Blood Pressure Research, January 2005, Karger Publishers

    Prof. Dr. Johannes Stegbauer

  100. Modulation of gene expression by moxonidine in rats with chronic renal failure

    Article • Nephrology Dialysis Transplantation, July 2004, Oxford University Press (OUP)

    Prof. Dr. Johannes Stegbauer

  101. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y 2 -receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, May 2004, Springer Science + Business Media

    Prof. Dr. Johannes Stegbauer

  102. Angiotensin-(1–7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats

    Article • Cardiovascular Research, February 2004, European Society of Cardiology

    Prof. Dr. Johannes Stegbauer

  103. AT1 and AT2-Receptor Antagonists Inhibit Ang II-Mediated Facilitation of Noradrenaline Release in Human Atria

    Article • Journal of Cardiovascular Pharmacology, February 2004, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer

  104. Effects of angiotensin-(1-7) and other bioactive components of the renin–angiotensin system on vascular resistance and noradrenaline release in rat kidney

    Article • Journal of Hypertension, July 2003, Wolters Kluwer Health

    Prof. Dr. Johannes Stegbauer